Anti-Factor Xa Plasma Levels in Pregnant Women Receiving Low Molecular Weight Heparin Thromboprophylaxis

被引：2
|
作者：
Pabinger, Ingrid [1 ]
Greinacher, Andreas [2 ]
机构：
[1] Med Univ Vienna, Dept Med 1, Clin Div Haematol & Haernostaseol, Vienna, Austria
[2] Ernst Moritz Arndt Univ Greifswald, Dept Transfus Med, Inst Immunol & Transfus Med, Greifswald, Germany
来源：
OBSTETRICS AND GYNECOLOGY | 2009年 / 113卷 / 03期
关键词：
VENOUS THROMBOEMBOLISM;
D O I：
10.1097/AOG.0b013e31819b3b38
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：740 / 740
页数：1
相关论文
共 50 条
  • [1] Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis
    Fox, Nathan S.
    Laughon, S. Katherine
    Bender, Samuel D.
    Saltzman, Daniel H.
    Rebarber, Andrei
    [J]. OBSTETRICS AND GYNECOLOGY, 2008, 112 (04): : 884 - 889
  • [2] Anti-factor Xa Plasma Levels in Pregnant Women Receiving Low Molecular Weight Heparin Thromboprophylaxis (vol 112, pg 884, 2008)
    Fox, N. S.
    Laughon, S. K.
    Bender, S. D.
    Saltzman, D. H.
    Rebarber, A.
    [J]. OBSTETRICS AND GYNECOLOGY, 2009, 114 (05): : 1148 - 1148
  • [3] Anti-factor Xa Plasma Levels in Pregnant Women Receiving Low Molecular Weight Heparin Thromboprophylaxis (vol 112, pg 884, 2008)
    Fox, N. S.
    Laughon, S. K.
    Bender, S. D.
    Saltzman, D. H.
    Rebarber, A.
    [J]. OBSTETRICS AND GYNECOLOGY, 2009, 113 (03): : 742 - 742
  • [4] Utility of anti-factor Xa levels in pregnant women receiving low molecular weight heparin prophylaxis
    Allred, Emily
    Quinn, Kristen
    Thorsen, Julia
    Pradarelli, Jason
    Baker, Lisa
    Szabo, Aniko
    Zhao, Shi
    Wassenaar, Timothy
    Kuhlman, Randall
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S280 - S280
  • [5] The anti-factor Xa range for low molecular weight heparin thromboprophylaxis
    Wei, Matthew Y.
    Ward, Salena M.
    [J]. HEMATOLOGY REPORTS, 2015, 7 (04) : 80 - 83
  • [6] HEPARIN AND LOW-MOLECULAR WEIGHT HEPARIN - IS ANTI-FACTOR XA ACTIVITY IMPORTANT
    LANE, DA
    RYAN, K
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1989, 114 (04): : 331 - 333
  • [7] Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients
    Yam, Lily
    Bahjri, Khaled
    Geslani, Van
    Cotton, Adrian
    Hong, Lisa
    [J]. PHARMACOTHERAPY, 2019, 39 (07): : 749 - 755
  • [8] Inability to predict subprophylactic anti-factor Xa levels in trauma patients receiving early low-molecular-weight heparin
    Imran, Jonathan B.
    Madni, Tarik D.
    Clark, Audra T.
    Rizk, Paul
    Huang, Emily
    Minshall, Christian T.
    Taveras, Luis R.
    Cunningham, Holly B.
    Eastman, Alexander L.
    Koshy, Jojo P.
    Kacir, Cory D.
    Cripps, Michael W.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2018, 85 (05): : 867 - 872
  • [9] Stability of low molecular weight heparin anti-factor Xa activity in citrated whole blood and plasma
    Birri, Nicole
    Baumgartner, Daniela
    Conte, Tiziana
    Huynh, Anh
    Weller, Katja
    Pavicic, Marko
    Reusser, Marianne
    Siegenthaler, Ilse
    Barizzi, Gabriela
    Alberio, Lorenzo
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (05) : 629 - 631
  • [10] Correlation between the low molecular weight heparin prophylactic dose and the plasma levels of anti Xa activity in pregnant women
    Mitic, G.
    Jurisic, Dj.
    Scekic, M.
    Spasic, D.
    Petkovic, M.
    Jakovljevic, B.
    Jelicic, Z. D.
    [J]. THROMBOSIS RESEARCH, 2009, 123 : S143 - S143
12345